Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 19,742 | 11,022 | 8,227 | 6,449 | 6,191 |
| Cost of Goods | 6,217 | 4,276 | 3,448 | 2,635 | 3,155 |
| Gross Profit | 13,525 | 6,746 | 4,779 | 3,814 | 3,035 |
| Operating Expenses | 10,080 | 8,078 | 10,079 | 9,466 | 6,326 |
| Operating Income | 3,662 | -1,056 | -4,852 | -5,017 | -3,136 |
| Interest Expense | 5 | 190 | 100 | 0 | 177 |
| Other Income | -28,662 | -1,269 | -3,090 | 22 | 12 |
| Pre-tax Income | -25,005 | -2,515 | -8,041 | -4,995 | -3,301 |
| Net Income Continuous | -25,005 | -2,515 | -8,041 | -4,995 | -3,301 |
| Minority Interests | N/A | N/A | -1,166 | -781 | -83 |
| Net Income | $-25,005 | $-2,515 | $-6,875 | $-4,214 | $-3,218 |
| EPS Basic Total Ops | -1.56 | -0.21 | -0.54 | -0.35 | -0.31 |
| EPS Basic Continuous Ops | -1.54 | -0.19 | -0.64 | -0.41 | -0.32 |
| EPS Diluted Total Ops | -1.56 | -0.21 | -0.54 | -0.35 | -0.31 |
| EPS Diluted Continuous Ops | -1.54 | -0.19 | -0.64 | -0.41 | -0.32 |
| EPS Diluted Before Non-Recurring Items | 0.14 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $4,000 | $-620 | $-4,305 | $-4,801 | $-2,865 |